Evidence map›Paper›PMID 26682233›Full record

ArticleJournal of diabetes research2016

Coenzyme Q10 Attenuates High Glucose-Induced Endothelial Progenitor Cell Dysfunction through AMP-Activated Protein Kinase Pathways.

Hsiao-Ya Tsai, Chih-Pei Lin, Po-Hsun Huang, Szu-Yuan Li, Jia-Shiong Chen, Feng-Yen Lin, Jaw-Wen Chen, Shing-Jong Lin

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Lipid metabolism ofWorld journal of diabetes · 2025
    Article
  2. Research Progress of Coenzyme Q in Diabetes Mellitus and Its Common Complications.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Role of Coenzyme QAntioxidants (Basel, Switzerland) · 2021
    Review
  8. Article
  9. In search of elixir: Pharmacological agents against stem cell senescence.Iranian journal of basic medical sciences · 2021
    Review
  10. The Use of Coenzyme Q10 in Cardiovascular Diseases.Antioxidants (Basel, Switzerland) · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. CoQ10 and Aging.Biology · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hsiao-Ya TsaiInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Chih-Pei LinDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan ; Department of Biotechnology and Laboratory Science in Medicine and Institute of Biotechnology in Medicine, National Yang-Ming University, Taipei, Taiwan.
Po-Hsun HuangInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan ; Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan ; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.
Szu-Yuan LiInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan ; Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Jia-Shiong ChenInstitute and Department of Pharmacology, National Yang-Ming University, Taipei, Taiwan.
Feng-Yen LinDepartment of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Jaw-Wen ChenDivision of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan ; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan ; Institute and Department of Pharmacology, National Yang-Ming University, Taipei, Taiwan ; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
Shing-Jong LinInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan ; Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan ; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan ; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan ; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
Taipei Veterans General Hospital · TWNational Yang Ming Chiao Tung University · TWTaipei Medical University · TWNational Yang Ming University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coenzyme Q10 (CoQ10), an antiapoptosis enzyme, is stored in the mitochondria of cells. We investigated whether CoQ10 can attenuate high glucose-induced endothelial progenitor cell (EPC) apoptosis and clarified its mechanism. EPCs were incubated with normal glucose (5 mM) or high glucose (25 mM) environment for 3 days, followed by treatment with CoQ10 (10 μM) for 24 hr. Cell proliferation, nitric oxide (NO) production, and JC-1 assay were examined. The specific signal pathways of AMP-activated protein kinase (AMPK), eNOS/Akt, and heme oxygenase-1 (HO-1) were also assessed. High glucose reduced EPC functional activities, including proliferation and migration. Additionally, Akt/eNOS activity and NO production were downregulated in high glucose-stimulated EPCs. Administration of CoQ10 ameliorated high glucose-induced EPC apoptosis, including downregulation of caspase 3, upregulation of Bcl-2, and increase in mitochondrial membrane potential. Furthermore, treatment with CoQ10 reduced reactive oxygen species, enhanced eNOS/Akt activity, and increased HO-1 expression in high glucose-treated EPCs. These effects were negated by administration of AMPK inhibitor. Transplantation of CoQ10-treated EPCs under high glucose conditions into ischemic hindlimbs improved blood flow recovery. CoQ10 reduced high glucose-induced EPC apoptosis and dysfunction through upregulation of eNOS, HO-1 through the AMPK pathway. Our findings provide a potential treatment strategy targeting dysfunctional EPC in diabetic patients.

Indexed as

AMP-Activated Protein KinasesApoptosisCell MovementCell ProliferationEndothelial Progenitor CellsGlucoseHumansLeukocytes, MononuclearMitochondriaNitric OxideReactive Oxygen SpeciesSignal TransductionUbiquinoneAMP-Activated Protein Kinasescoenzyme Q10GlucoseNitric OxideReactive Oxygen SpeciesUbiquinone

Identifiers

PMID26682233
PMCPMC4670652
OpenAlexW1500206619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.